Imexpharm announces interim results for H1

Imexpharm announces interim results for H1

Imexpharm Corporation has announced its interim results for the first six months of 2024.
Imexpharm making inroads in achieving sustainable efficiency

Imexpharm making inroads in achieving sustainable efficiency

After four decades of development, Imexpharm Corporation has reaffirmed its position as a market leader in Vietnam’s pharmaceutical industry by investing in sustainable technology and human resources.